BRIEF published on 03/19/2025 at 15:32, 21 days 15 hours ago Valerio Therapeutics Announces Board Members and Their Roles Board Members Valerio Therapeutics Corporate Roles Paris-based Company Executive Responsibilities
PRESS RELEASE published on 03/19/2025 at 15:27, 21 days 15 hours ago Inside Information / Other news releases Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025 Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF published on 03/19/2025 at 12:35, 21 days 18 hours ago Valerio Therapeutics Board Meeting Decisions Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments
PRESS RELEASE published on 03/19/2025 at 12:30, 21 days 18 hours ago Inside Information / Other news releases Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
BRIEF published on 02/04/2025 at 10:40, 2 months 5 days ago Valerio Therapeutics opts for strategic refocusing Clinical Trials Oncology Financial Strategy Medical Innovation Valerio Therapeutics
PRESS RELEASE published on 02/04/2025 at 10:35, 2 months 5 days ago Inside Information / Other news releases Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
BRIEF published on 10/01/2024 at 00:56, 6 months 9 days ago Valerio Therapeutics Reports First Half 2024 Financial Results Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies
BRIEF published on 10/01/2024 at 00:45, 6 months 9 days ago Valerio Therapeutics Reports Half-Year 2024 Financial Results and Strategic Updates Financial Results Emglev Acquisition VIO-01 Clinical Trial PlatON™ Platform Therapeutic Innovations
PRESS RELEASE published on 10/01/2024 at 00:40, 6 months 9 days ago Inside Information: News release on accounts, results Valerio Therapeutics reports its half-year 2024 financial results and updates on its activities, including the acquisition of Emglev Therapeutics and progress on the VIO-01 trial Acquisition Financial Results Valerio Therapeutics VIO-01 Trial Emglev Therapeutics
PRESS RELEASE published on 09/30/2024 at 22:40, 6 months 9 days ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
Published on 04/10/2025 at 06:08, 55 minutes ago Tocvan Commences Drilling at Gran Pilar Gold - Silver Project Continues Expansion Zone Drilling Along Northern Corridors
Published on 04/10/2025 at 02:30, 4 hours 33 minutes ago Star Copper Completes Non-Brokered Private Placement for Proceeds of $2,500,000
Published on 04/09/2025 at 23:30, 7 hours 33 minutes ago AirIQ Announces Major Customer Win Accelerating Growth in Recurring Revenue
Published on 04/09/2025 at 22:17, 8 hours 46 minutes ago Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
Published on 04/10/2025 at 06:30, 32 minutes ago Avolta Publishes Invitation to its Annual General Meeting, to be held on May 14, 2025
Published on 04/10/2025 at 04:55, 2 hours 8 minutes ago CO2Coin one of the most successful crypto investments of the coming decades.
Published on 04/09/2025 at 20:20, 10 hours 43 minutes ago Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences
Published on 04/09/2025 at 20:18, 10 hours 45 minutes ago EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG publishes preliminary key figures for the financial statements as of March 31, 2025
Published on 04/09/2025 at 18:59, 12 hours 3 minutes ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 12 hours 5 minutes ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 13 hours 18 minutes ago COGELEC : 2024 full-year results and Q1 2025 revenue.
Published on 04/09/2025 at 17:40, 13 hours 23 minutes ago COGELEC : Statement on the total number of shares and voting rights.
Published on 04/09/2025 at 08:00, 23 hours 3 minutes ago Museum Studio becomes a majority shareholder in Lord Cultural Resources
